GRANTRYL

This brand name is authorized in South Africa

Active ingredients

The drug GRANTRYL contains one active pharmaceutical ingredient (API):

1 Granisetron UNII 318F6L70J8 - GRANISETRON HYDROCHLORIDE

Granisetron is a potent anti-emetic and highly selective antagonist of 5-hydroxytryptamine (5HT3 receptors). Pharmacological studies have demonstrated that granisetron is effective against nausea and vomiting as a result of cytostatic therapy. Read about Granisetron

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GRANTRYL Film-coated tablet	Health Products Regulatory Authority (ZA)	MPI, Generic
GRANTRYL Solution for injection	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A04AA02	Granisetron	A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AA Serotonin (5HT3) antagonists
Discover more medicines within A04AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/5.7.2/0527, 43/5.7.2/0528, 44/5.7.2/0892, 44/5.7.2/0893